Home › Atrial Fibrillation › NCT05504356
Volunteers to Investigate Best Results for Ablation and Novel Therapies for Atrial Fibrillation
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Adults age 18 and older * Must have a smartphone device (iOS and/or Android) and cell phone number to participate on the mobile app, and will be willing to download the Eureka Research Platform mobile application * Must have email address to participate on the web portal (accessible on any web-connected device) * Undergone a catheter ablation procedure for atrial fibrillation in the week prior to recruitment, or have an ablation planned for within a week from recruitment Exclusion Criteria: * Unable to consent for themselves * Unable to read, speak, comprehend English
About the study
VIBRANT-AF seeks to:
* Identify clinically relevant predictors of effectiveness and complications of AF ablation procedures in a prospective, US-based, multi-center, real-world longitudinal study * Assess changes in modifiable lifestyle-related exposures influence the effectiveness of AF ablation * Determine incidence and predictors of complications of AF ablation procedures
Participants will connect with the Eureka Research Platform and answer a series of surveys and activities over a one-year period. They will be asked about lifestyle habits, recurrence of AFib, hospitalizations, and general feelings and emotions.
Sponsor: University of California, San Francisco · Participants: 1,125 · Started: Apr 27, 2022
Contact the study team
- Bella Peña, BA · Phone: 415-502-3053
- Hannah Oo, BS · Phone: 415-476-4999
Official record on ClinicalTrials.gov — NCT05504356
Locations in the U.S.
| California | University of California, San Francisco, San Francisco |
Conditions
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.